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Objective – To investigate whether there is a systematic difference in peripapillary retinal 
nerve fiber layer (pRNFL) thickness measurements between subsequent updates of pRNFL 
segmentation software provided by Heidelberg Spectralis optical coherence tomography 
(OCT). 
Methods – In total, 838 pRNFL scans from 213 multiple sclerosis (MS) patients and 61 
healthy controls were analysed. All pRNFL scans were performed on the same OCT device 
followed by automated segmentation (HRA 5.6.4.0) and data extraction. Subsequently, all 
scans were re-segmented with an updated software version (HRA 6.0.7.0). To assess level of 
agreement between the two algorithms, Bland-Altman Plots (BAP) were constructed. Paired 
samples T-test and linear regression analyses were used to investigate for differences in mean 
thickness and proportional bias respectively. 
Results – Overall, the updated version showed an overestimation of 0.16 µm [95%CI 0.097 – 
0.23, p<0.001] for the global pRNFL thickness compared to the earlier version. The largest 
differences were found for the nasal inferior (mean ∆ 0.29 µm, p<0.001) and temporal inferior 
(mean ∆ 0.43 µm, p<0.001) sectors. Inspection of the BAP revealed that the difference 
between the two versions could be up to 6 µm for the global mean. There was no proportional 
bias for the global mean (β=0.003, p=0.245) nor for any of the separate sectors. 
Conclusion – The data show a significant difference in pRNFL thickness measurements 
between two subsequent versions of the same segmentation software. Although the mean 
difference was relatively small, the differences within the individual subject could be 





Optical coherence tomography (OCT) is a non-invasive imaging technique that allows for 
detailed imaging and quantification of the thickness of individual retinal layers.(1, 2) Having 
gained wide acceptance in the ophthalmology practice for the evaluation of various primary 
ocular disorders, OCT is employed more and more in the assessment of neurodegenerative 
disorders as well, particularly in multiple sclerosis (MS).(3, 4) Cross-sectional studies in MS 
patients have demonstrated a link between atrophy of the peripapillary retinal nerve fiber 
layer (pRNFL), and various (para)clinical parameters of neurodegeneration including physical 
disability, cognitive impairment and brain atrophy.(5-7) Current studies focus on longitudinal 
atrophy measurements in the hope of being able to predict which MS patients will develop 
physical or cognitive disability.  
The assessment of retinal atrophy has improved considerably with the introduction of spectral 
domain OCT (compared to the previously used time-domain OCT), allowing for reliable 
quantification of individual retinal layers.(8) In addition, automated retinal layer segmentation 
algorithms have not only replaced the time consuming and demanding task of manual 
segmentation but have also increased the accuracy of retinal layer thickness measurements. 
Subsequent updates in these algorithms aim at refining these aspects by decreasing the 
processing time and increasing accuracy.(9) The Spectralis OCT by Heidelberg Engineering 
is  frequently used for clinical and research purposes in a MS setting and gets updated 
regularly with newer versions of the segmentation algorithm. 
Nevertheless, in a longitudinal setting there is the potential of biased measurements if not all 
subsequent scans are segmented using the same software version. This problem can occur due 
to the difference in the manner of segmentation (for example how the algorithm handles 
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artefacts due to blood vessels). Therefore, the aim of this study was to investigate whether 
there is a systematic difference in pRNFL thickness measurement between subsequent 





For this cross-sectional study, scans were used from participants of the prospective 
Amsterdam MS Cohort. The inclusion criteria for this cohort have been described 
previously.(10) At baseline, this cohort consisted of 230 patients and 63 healthy controls 
(HCs). Patients were retested after a period of two years. Both the baseline and the follow-up 
scans were used in this study. All examinations (clinical, OCT etc.) were performed on the 
same day. 
This study was approved by the medical ethics committee and scientific research committee 
of the VU University Medical Center and was conducted in accordance with the declaration 
of Helsinki. Written informed consent was obtained from every participant. 
 
OCT acquisition and segmentation 
OCT imaging was performed in all subjects on a Spectralis spectral domain OCT (Heidelberg 
Engineering, Heidelberg, Germany) with dual beam simultaneous imaging and the eye 
tracking function enabled.(11) All scans, baseline as well as the follow-up scans, were 
acquired using the same acquisition software (version 1.7.1.0.). In order to measure pRNFL 
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thickness a 12° ring scan (1536 A-scans, no predetermined automatic real time) manually 
centred around the optic nerve head was performed. Follow-up scans were acquired using the 
automatic follow-up function in order to be sure the scans were made at the exact same 
location. The scans were segmented using software provided by the manufacturer, HRA / 
Spectralis Viewing Module 5.6.4.0 and the data was exported for statistical analysis. 
Subsequently, the scans were re-segmented using an updated version of the software, HRA / 
Spectralis Viewing Module 6.0.7.0, and again exported. After both segmentation procedures, 
quality control was performed according to the OSCAR-IB criteria(12) and scans were 
rejected if they failed one or more criteria. Special attention was paid to the algorithm failure 
criterion. Scans with obvious algorithm failures were rejected. In contrast, scans with small, 
debatable segmentation deviations (i.g. due to blood vessels), which would normally be 
accepted for any other study, were included. These scans were not corrected manually in 
order to be able to investigate the potential bias of the segmentation algorithms, instead of the 
bias caused by manual correction.  
 
Statistical analysis 
All statistical analyses were performed using SPSS version 22.0. Normality was assessed 
visually by means of histograms. Differences in subject characteristics were tested using 
student T-test (parametric variables), Mann-Whitney-U test (nonparametric variables) and chi 
square test (categorical variables). Bland-Altman plots were constructed by calculating the 
mean difference (systematic bias) and 95% limits of agreement of the thickness measured by 
the two software versions.(13) The thickness measured by version 5.6.4.0 was always 
subtracted from the thickness measured by version 6.0.7.0, meaning that a positive difference 
indicates that version 6.0.7.0 measured a thicker pRNFL. Mean differences in retinal layer 
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thickness between the two versions were tested using the paired samples T-test. Proportional 
bias was tested by means of linear regression analyses. Linear regression was also used to test 
the association between the absolute difference in pRNFL thickness between the two versions 
and the number of averaged B-scans (expressed by automated real time, ART). Subgroup 
analyses were performed comparing the systematic bias in patients and HCs. Lastly, 
longitudinal changes in pRNFL thickness were calculated for both software versions. 
Subsequently, the difference in the amount of progressive atrophy between the two versions 
was tested using paired samples T-test. All analyses were performed for the mean thickness of 
the entire pRNFL (global mean) as well as the six individual sectors: temporal superior (TS), 
temporal (T), temporal inferior (TI), nasal inferior (NI), nasal (N) and nasal superior (NS). 




For this cross-sectional study, 802 scans from 230 patients and 211 scans from 63 HCs were 
available for review. After quality control, 150 patient scans (18.7%) and 25 HC scans 
(11.8%) were rejected. This lead to the inclusion of 652 scans (353 baseline and 299 follow-
up) from 213 MS patients and 186 scans (113 baseline and 73 follow-up) from 61 HCs.  
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The baseline characteristics of these 213 patients and 61 HCs are shown in Table 1. 
Compared to patients HCs were younger (mean difference 3.6 years, p=0.001). Patients had a 
mean disease duration of 20.2 years and showed a considerable level of disability which is 
reflected in the median EDSS score of 4.0. Most patients had a relapsing remitting disease 
course. As expected patients showed considerably more atrophy of the pRNFL compared to 
HCs (mean difference 11.20 µm, p<0.001). 
 
Mean thickness by sector 
Table 2 shows the average of the global mean and the six separate sectors for all scans as 
calculated by both software versions. There was a significant difference for the global mean, 
with version 6.0.7.0 showing a thicker pRNFL compared to version 5.6.4.0 (mean difference 
0.16 µm, p<0.001). The largest difference in mean thickness between the two versions was 
found for the NI and TI sectors (NI 0.29 µm, p<0.001; TI 0.43 µm, p<0.001). The N sector 
showed a significant difference as well, with a mean difference of 0.14 µm, p=0.015. On the 
contrary, there was no significant difference in mean thickness between the two software 
versions for the T, TS or NS sector.  The median difference was 0.0 µm for the global mean 
as well as for all of the sectors. 
 
Bland-Altman plots and proportional bias 
Figure 1 shows the Bland-Altman plot for the global mean of all scans combined. The dotted 
lines represent the bias (mean difference) and 95% levels of agreement. As illustrated, most 
scans showed no or only a small difference of 1 or 2 µm. Nevertheless, a considerable part of 
the scans showed larger differences with a maximum of up to 6 µm. There was no 
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proportional bias (β = 0.003, p = 0.245) for the global mean pRNFL thickness, meaning that 
the difference in thickness measured by the two segmentation software versions was 
independent of the thickness of the pRNFL.  
As described earlier, only the NI, TI and N sectors showed a significant difference in 
thickness measured by the two software versions. The Bland-Altman plots for these three 
sectors are displayed in Figure 2. All three sectors, and especially the NI and TI sectors, 
showed  considerable variability in the difference in thickness measured, with outliers of up to 
-27 µm for the NI sector. This sector has a high density of retinal vessels. Again, there was no 
proportional bias for any of the sectors.  
We also examined whether the systemic systematic bias in pRNFL thickness measurement 
was different in patients compared to HCs. The patient scans showed a mean difference of 
0.15 µm between the two versions and the HC scans showed 0.19 µm. This difference of 
0.039 µm was statistically not significant (p=0.634).  
To get an indication whether scan ‘quality’ (is this right?)  influenced the segmentation results 
we investigated the association between ART and the difference in pRNFL thickness between 
the two software versions. The median ART was 31 with a range of 1 - 100. There was no 
significant association for the global mean (β = -0.001, p=0.451). The N and T sectors did 
however show a small, yet significant, inverse association (N β = -0,003, p=0.047; T β = -
0.002, p=0.008). The other four sectors did not show any significant associations.   
 
The effect on longitudinal atrophy measurements  
39 HCs: show the same amount of longitudinal atrophy: op een hoop gooien of ??? 
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A total of 178 MS patients completed the two year follow-up. Using the initial software 
version (5.6.4.0) for both the baseline and follow-up visits, these patients showed a decline in 
pRNFL thickness of -0.95 µm (95%CI -0.67 – -1.22, p<0.001). When using the later software 
version (6.0.7.0) the amount of atrophy was slightly less, -0.71 µm (95%CI -0.46 – -0.96, 
p<0.001). This difference of 0.18 µm was statistically significant (p=0.006).  
The amount of atrophy in the most extreme case was also calculated. In this scenario, where 
the baseline scans would be segmented with version 5.6.4.0 and the follow-up scans with 
version 6.0.7.0 the amount of atrophy the patients showed was -0.63 µm (95%CI -0.37 to  -
0.89, p<0.001) This was significantly lower than the amount of atrophy showed when all 
scans were segmented with version 5.6.4.0 (mean difference 0.32 µm, p<0.001) but not when 




This study shows that there is a significant, systematic difference in the pRNFL thickness 
measurement between two subsequent software updates of the retinal layer segmentation 
algorithm provided by the Heidelberg Spectralis OCT. Although the mean difference was 
relatively small (yet significant), the difference between the two algorithms in individual 
scans could be as high as 6 µm for the global mean pRNFL thickness. This last finding is an 
important one if we plan on using OCT as a surrogate marker for neurodegeneration in 
individual patients. The expected rate of pRNFL atrophy in MS patients is about 1-2 µm/year 
(5, 14, 15) and is even lower in patients with a longer disease duration.(16) A large part of our 
scans showed a degree of difference in pRNFL thickness measurement between the two 
versions that could mask or overestimate the true pRNFL atrophy, which is presumed to be 
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caused by retrograde trans-synaptic degeneration.(17)  In addition, the study shows that using 
different software versions does in fact influence longitudinal atrophy measurements.   To our 
knowledge, this is the first study that has investigated this methodological issue. The findings 
are relevant and should be considered by regulatory authority for approval of OCT 
segmentation software. Producers will need to be aware of the need to potentially update their 
segmented normative databases. 
Current Spectralis OCT machines provide pRNFL thickness measurements directly after 
scanning. This process is done automatically and according to the last installed segmentation 
algorithm. However, even when the follow-up scanning function is used, the previous 
(baseline) scan retains its previous segmentation. So, if the OCT device gets updated with a 
new version of the segmentation algorithm in between patient assessments, a measurement 
error can be introducesd easily. It is therefore important to make sure that the baseline as well 
as each subsequent follow-up scan is segmented by the same software version. In the case of 
the Heidelberg Spectralis OCT this can be done quite easily and quickly by opening the 
previous scans and intentionally segmenting them again. In our experience, it is, in most 
scans, visible that the line between the RNFL and ganglion cell layer replaces when the scan 
is re-segmented. In contrast, the line indicating the inner limiting membrane remains very 
stable. For illustration, Figure 3 shows three examples of (obvious) differences in 
segmentation between the two software versions. All three scans were of high quality and the 
segmentation would be accepted in all cases. Nevertheless, there was a difference in pRNFL 
thickness between the two software versions.  
There are other factors which need to be considered because they can also influence pRNFL 
thickness measurements, for instance the interobserver and intraobserver variability. 
However, it has been shown that both the inter- as well as intraobserver variability are 
generally high when only those scans that have passed the OSCAR-IB criteria are selected, as 
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is the case in our study.(18) One specific  confounder that is especially relevant in 
longitudinal studies is off-axis beam placement, which can introduce a large error.(19) To our 
knowledge, the potential error of off-center beam placement is not dependent on the software 
version. Nevertheless, while exact beam placement at subsequent scans can be quite tricky, 
making sure every scan is segmented with the same software version is rather simple. 
One of the strengths of this study is the statistical robustness due to the large sample size. We 
chose to analyse scans from both patient as well as HCs. One could argue that patient scans 
are generally of poorer quality (due to problems with fixation for example) and are thus more 
prone to (small) segmentation errors leading to a difference in thickness measurements. 
However, we could not find a significant difference in the systemic systematic bias between 
patient scans and HC scans. Although the ART did not affect the the difference in global 
pRNFL thickness, there were small but significant associations for the N and T sectors, which 
may indicate that higher ART is associated with a smaller difference between the software 
versions. However, as all scans were of sufficient quality, we cannot say with certainty that 
the differences in segmentation occur more easily with lower quality scans. Another strength 
of this study is that we performed OSCAR-IB quality control. We only included those scans 
that would pass the quality control if they were to be used in any other study or clinical 
practice. 
A limitation of this study is the fact that we did not investigate whether this problem also 
occurs with OCT machines and segmentation software by other manufacturers. For example, 
a number of studies in MS have been performed with the Cirrus OCT by Carl Zeiss Meditec 
(N=15) and 3D OCT-1000 / 2000 by Topcon Corporation (N=5). A recent meta-analysis by 
Petzold et al. showed that of all the studies investigating pRNFL atrophy in MS patients with 
and without optic neuritis, seventeen have been performed with the Spectralis OCT, fourteen 
with the Cirrus OCT by Carl Zeiss Meditec and four with the 3D-OCT-1000 / 2000 by 
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Topcon Corporation.(20) A literature review on longitudinal SD-OCT studies revealed that 
six have been performed with the Spectralis OCT(16, 21-25) and five with the Cirrus 
OCT(15, 26-29). It is plausible that this problem might occur with these OCT devices as well, 
but this still remains to be investigated and these groups are well placed to investigate this 
point. 
In conclusion, this study has demonstrated that updates in pRNFL segmentation software lead 
to a significant difference in pRNFL thickness measurement, especially when analysing 
individual patient scans. Therefore, we recommend that all scans are segmented with the same 
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Table 1: Characteristics of the study cohort.  
 Patients 
N = 213 
Healthy controls 
N = 61 
p-value 
Age (years), mean (± SD) 53.8 (9.8) 50.2 (7.0) 0.001 
Sex (female : male) 147 : 66 41 : 20 0.789 
Disease duration (years), 
mean (± SD) 
20.2 (6.9) N/a  
EDSS, median [range] 4.0 [1.0 – 8.0] N/a  











pRNFL thickness, mean 
(± SD)*  
83.36 (7.65) 94.56 (14.14) < 0.001 
* measured with version 6.0.7.0 
SD = Standard Deviation; EDSS = Expanded Disability Status Scale; MS = Multiple 
Sclerosis; RR = Relapsing Remitting; SP = Secondary Progressive; PP = Primary 
Progressive; pRNFL = peripapillary Retinal Nerve Fiber Layer  
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Table 2: Mean pRNFL thickness and proportional bias for the global mean and each of 
the six separate sectors as measured by the two software versions. Proportional bias was 









µm (± SD) 





Global Mean 85.22 (13.87) 85.06 (13.83) <0.001 0.003 0.245 
Nasal Superior 92.55 (20.05) 92.47 (20.11) 0.114 -0.003 0.247 
Nasal  63.68 (11.45) 63.55 (11.36) 0.015 0.006 0.120 
Nasal Inferior  96.90 (23.15) 96.62 (23.24) <0.001 -0.004 0.241 
Temporal Inferior  124.37 (23.12) 123.94 (22.98) <0.001 0.006 0.157 
Temporal  59.60 (14.99) 59.62 (15.02) 0.402 -0.001 0.437 
Temporal Superior 121.31 (21.50) 121.16 (21.32) 0.162 0.009 0.081 
 
pRNFL = peripapillary Retinal Nerve Fiber Layer; SD = Standard Deviation  
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Figure 1: Bland-Altman Plot for the global mean pRNFL thickness. The difference in 
pRNFL thickness between the two segmentation software versions (y-axis) is plotted against 
the average of the two measurements (x-axis). The blue line represent the regression line to 
test for proportional bias. The middle broken line represents the mean difference (systematic 
bias) in pRNFL thickness for all scans combined. The top and bottom broken lines represent 
the 95% limits of agreement.  
 
pRNFL = peripapillary Retinal Nerve Fiber Layer  
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Figure 2: Bland-Altman plots of the three sectors that showed a significant difference in 
pRNFL thickness between the two segmentation software versions. The difference in 
pRNFL thickness between the two segmentation software versions (y-axis) is plotted against 
the average of the two measurements (x-axis). The middle broken line represents the mean 
difference (systematic bias) in pRNFL thickness for all scans combined. The top and bottom 
broken lines represent the 95% limits of agreement. Notice that the scale on the y-axis has 
been enlarged in comparison to Figure 1.   
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Figure 3: Three examples of differences in segmentation between the two software 
versions. The top image is segmented with version 5.6.4.0 and the bottom image with version 
6.0.7.0. The mean thickness of the entire pRNFL (global mean) is given in white. 
 
